1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Pulmonary Drug Delivery Devices Market
2.2. Global Pulmonary Drug Delivery Devices Market, By Technology, 2023 (US$ Million)
2.3. Global Pulmonary Drug Delivery Devices Market, By Application, 2023 (US$ Million)
2.4. Global Pulmonary Drug Delivery Devices Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Pulmonary Drug Delivery Devices Market: Competitive Analysis
3.1. Market Positioning of Key Pulmonary Drug Delivery Devices Market Vendors
3.2. Strategies Adopted by Pulmonary Drug Delivery Devices Market Vendors
3.3. Key Industry Strategies
4. Pulmonary Drug Delivery Devices Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Pulmonary Drug Delivery Devices Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Dry Powder Inhalers
5.3.1.1. Single-dose inhalers
5.3.1.2. Multi-dose inhalers
5.3.2. Metered Dose Inhalers
5.3.2.1. Manually-actuated pressurized inhaler
5.3.2.2. Breath-actuated pressurized inhaler
5.3.3. Nebulizers
5.3.3.1. Jet nebulizers
5.3.3.2. Ultrasonic wave nebulizers
5.3.3.3. Vibrating mesh nebulizers

6. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Asthma
6.3.2. COPD
6.3.3. Cystic fibrosis
6.3.4. Diabetes
6.3.5. Others (allergic rhinitis, tuberculosis, among others)


7. North America Pulmonary Drug Delivery Devices Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
7.3. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
7.4.Pulmonary Drug Delivery Devices Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
7.4.1.1.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
7.4.1.2.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
7.4.1.3.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)

8. UK and European Union Pulmonary Drug Delivery Devices Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
8.3. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
8.4.Pulmonary Drug Delivery Devices Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
8.4.1.1.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
8.4.1.2.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
8.4.1.3.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
8.4.1.4.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
8.4.1.5.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
8.4.1.6.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)

9. Asia Pacific Pulmonary Drug Delivery Devices Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
9.3. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
9.4.Pulmonary Drug Delivery Devices Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
9.4.1.1.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
9.4.1.2.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
9.4.1.3.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
9.4.1.4.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
9.4.1.5.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
9.4.1.6.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)

10. Latin America Pulmonary Drug Delivery Devices Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
10.3. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
10.4.Pulmonary Drug Delivery Devices Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
10.4.1.1.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
10.4.1.2.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
10.4.1.3.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)

11. Middle East and Africa Pulmonary Drug Delivery Devices Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
11.3. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
11.4.Pulmonary Drug Delivery Devices Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
11.4.1.1.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
11.4.1.2.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Pulmonary Drug Delivery Devices Market: By Technology, 2022-2032, USD (Million)
11.4.1.3.2. Pulmonary Drug Delivery Devices Market: By Application, 2022-2032, USD (Million)

12. Company Profile
12.1. Boehringer Ingelheim GmbH
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Novartis AG
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. GlaxoSmithKline plc
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. AstraZeneca plc
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Teva Pharmaceutical Industries Ltd.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Merck & Co., Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. MannKind Corporation
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. F. Hoffmann-La Roche Ltd.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Bristol-Myers Squibb Company
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Mylan N.V.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Omron Corporation
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. 3M Healthcare
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Sunovion Pharmaceuticals, Inc.
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Koninklijke Philips N.V.
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
12.15. Gerresheimer AG
12.15.1. Company Overview
12.15.2. Financial Performance
12.15.3. Product Portfolio
12.15.4. Strategic Initiatives
12.16. Bespak
12.16.1. Company Overview
12.16.2. Financial Performance
12.16.3. Product Portfolio
12.16.4. Strategic Initiatives
12.17. AptarGroup, Inc.
12.17.1. Company Overview
12.17.2. Financial Performance
12.17.3. Product Portfolio
12.17.4. Strategic Initiatives
12.18. SHL Group
12.18.1. Company Overview
12.18.2. Financial Performance
12.18.3. Product Portfolio
12.18.4. Strategic Initiatives
12.19. Nypro Healthcare Inc.
12.19.1. Company Overview
12.19.2. Financial Performance
12.19.3. Product Portfolio
12.19.4. Strategic Initiatives
12.20. Chiesi Farmaceutici S.p.A.
12.20.1. Company Overview
12.20.2. Financial Performance
12.20.3. Product Portfolio
12.20.4. Strategic Initiatives
12.21. Hovione
12.21.1. Company Overview
12.21.2. Financial Performance
12.21.3. Product Portfolio
12.21.4. Strategic Initiatives